Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Ultrasound Group

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06554249Not ApplicableUnknownPrimary

Full Bladder IUD Insertion Without Vulsellum Under Ultrasound Guidance

NCT00561613Phase 1CompletedPrimary

Postcoital Testing of the SILCS Diaphragm

Showing all 2 trials

Research Network

Common Treatments

  • Ultrasound Group1
  • Vulsellum Group1
  • Silcs And Spermicide1
  • Silcs And Lubricant1

Active Sponsors

  • CONRAD1
  • Cairo University1
  • Bedaya Hospital1

Top Investigators

Activity Timeline